ARTV insider buying

7 cluster buys

Artiva Biotherapeutics, Inc.

When two or more insiders at Artiva Biotherapeutics, Inc. buy ARTV on the open market around the same time, that clustered conviction is one of the highest-signal patterns in SEC filing data. Below is every cluster we've detected in ARTV plus the full record of qualifying open-market buys, each parsed directly from Form 4 filings and linked back to the source on SEC EDGAR.

Clusters
7
Distinct insiders
7
Total bought
$273.7M
Market cap
Unknown

Detected clusters

  • May 11 – Jul 24, 2026
    Detected Jul 28, 2026
    2 insiders
    Total bought
    $108.7M
    Market cap
    Unknown
  • May 11 – Jul 23, 2026
    Detected Jul 24, 2026
    2 insiders
    Total bought
    $108.3M
    Market cap
    Unknown
  • May 11 – Jul 17, 2026
    Detected Jul 24, 2026
    2 insiders
    Total bought
    $105.7M
    Market cap
    Unknown

4 more clusters in ARTV

Sign in free to see the full history, or go Pro for real-time alerts the moment new insider clusters form.

All notable open-market buys in ARTV

Every open-market Form 4 purchase, newest first. Click an insider to see their full buying record across companies.

DateInsiderSharesPriceValueFiling
Jul 24, 2026
Director, 10% Owner
41,319$9.99$412.8KSEC ↗
Jul 23, 2026
Director, 10% Owner
59,880$9.96$596.4KSEC ↗
Jul 22, 2026
Director, 10% Owner
84,124$9.93$835.4KSEC ↗
Jul 21, 2026
Director, 10% Owner
120,582$9.55$1.2MSEC ↗
Jul 17, 2026
Director, 10% Owner
7,882$8.95$70.5KSEC ↗
Jul 16, 2026
Director, 10% Owner
152,472$8.93$1.4MSEC ↗
Jul 13, 2026
Director, 10% Owner
6,552$8.94$58.6KSEC ↗
Jul 13, 2026
Director, 10% Owner
6,522$8.94$58.3KSEC ↗
Jul 10, 2026
Director, 10% Owner
15,102$8.97$135.5KSEC ↗
Jun 25, 2026
Director, 10% Owner
31,000$8.88$275.3KSEC ↗
Jun 16, 2026
Director, 10% Owner
124,893$8.89$1.1MSEC ↗
Jun 15, 2026
Director, 10% Owner
15,414$8.99$138.6KSEC ↗
Jun 12, 2026
Director, 10% Owner
391,019$8.57$3.4MSEC ↗
Jun 11, 2026
Director, 10% Owner
548,580$7.91$4.3MSEC ↗
Jun 9, 2026
Director, 10% Owner
479,039$6.91$3.3MSEC ↗
May 11, 2026
Director, 10% Owner
6,510,416$11.52$75.0MSEC ↗
May 11, 2026
GC Corp.cluster
10% Owner
1,085,069$11.52$12.5MSEC ↗
May 11, 2026
GC Corp.cluster
10% Owner
347,222$11.52$4.0MSEC ↗
Jul 22, 2024
Director, 10% Owner
7,645,007$12.00$91.7MSEC ↗
Jul 22, 2024
10% Owner
1,666,666$12.00$20.0MSEC ↗
Jul 22, 2024
Director
1,666,666$12.00$20.0MSEC ↗
Jul 22, 2024
10% Owner
833,333$12.00$10.0MSEC ↗
Jul 22, 2024
Director, 10% Owner
688,326$12.00$8.3MSEC ↗
Jul 22, 2024
10% Owner
416,666$12.00$5.0MSEC ↗
Jul 22, 2024
Director
416,666$12.00$5.0MSEC ↗
1 earlier buy hidden — sign in free to see the full history.

ARTV insider buying — FAQ

Are insiders buying ARTV stock?
Yes — 7 distinct insiders have bought ARTV (Artiva Biotherapeutics, Inc.) on the open market, including 7 cluster buys where two or more insiders bought within a rolling window. The most recent qualifying activity was Jul 28, 2026.
How much ARTV stock have insiders bought?
Insiders have bought a combined $273.7M of ARTV across 26 open-market purchases, based on SEC Form 4 filings.
What is an insider cluster buy in ARTV?
A cluster buy is two or more distinct Artiva Biotherapeutics, Inc. insiders — officers, directors, or 10% owners — each buying ARTV on the open market within a rolling window. ARTV has 7 detected cluster buys to date.
Where does this ARTV insider trading data come from?
Every figure is parsed directly from SEC Form 4 filings on EDGAR, and each purchase on this page links back to its original filing document.

How we track insider buying in ARTV

We continuously poll SEC EDGAR for new Form 4 filings and parse every open-market purchase (transaction code P). A cluster is recorded when two or more distinct insiders — officers, directors, or 10% owners — each buy ARTV within a rolling window. We track clusters at every company size, from micro-caps to mega-caps. Every figure on this page traces back to an official filing; open any row to jump straight to the source document. What counts as a cluster buy?

This page is informational and reflects public filing data. It is not investment advice or a recommendation regarding ARTV.